Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Sotagliflozin Prototypes in Healthy Subjects
NCT03310944Phase 1Completed
- Sponsor
- Sanofi
- Start
- Oct 2017
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of sotagliflozin in type 1 diabetes mellitus (T1D) and type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Sanofi. Primary endpoints: Area Under the Curve, Area Under the Curve to Last Quantifiable Concentration and 1 more. Started Oct 2017; status: completed.
02
Drugs
sotagliflozin
03
Conditions
type 1 diabetes mellitus (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03310944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03310944.